Aralez Pharmaceuticals Inc. 4
4 · Aralez Pharmaceuticals Inc. · Filed May 18, 2016
Insider Transaction Report
Form 4
Glickman Mark A
Chief Commercial Officer
Transactions
- Purchase
Common Shares, without par value
2016-05-16$3.68/sh+25,000$92,050→ 186,553 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $3.64 to $3.72, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.